| NDC Code | 0003-7125-11 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 0003-7125 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Opdualag |
|---|
| Non-Proprietary Name | Nivolumab And Relatlimab-rmbw |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20220318 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761234 |
|---|
| Manufacturer | E.R. Squibb & Sons, L.L.C. |
|---|
| Substance Name | NIVOLUMAB; RELATLIMAB |
|---|
| Strength | 12; 4 |
|---|
| Strength Unit | mg/mL; mg/mL |
|---|
| Pharmacy Classes | Lymphocyte Activation Gene-3 Antagonists [MoA], Lymphocyte Activation Gene-3 Blocker [EPC], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
|---|